DE69616484T2 - Verwendung vom 3-Alpha-Hydroxy-5Alpha-Androsta-16-ene als Arzneimittel - Google Patents
Verwendung vom 3-Alpha-Hydroxy-5Alpha-Androsta-16-ene als ArzneimittelInfo
- Publication number
- DE69616484T2 DE69616484T2 DE69616484T DE69616484T DE69616484T2 DE 69616484 T2 DE69616484 T2 DE 69616484T2 DE 69616484 T DE69616484 T DE 69616484T DE 69616484 T DE69616484 T DE 69616484T DE 69616484 T2 DE69616484 T2 DE 69616484T2
- Authority
- DE
- Germany
- Prior art keywords
- alpha
- androsta
- ene
- hydroxy
- 5alpha
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9514750A FR2742337B1 (fr) | 1995-12-13 | 1995-12-13 | Application du 3-alpha-hydroxy-5-alpha-androsta-16-ene a titre de medicaments |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69616484D1 DE69616484D1 (de) | 2001-12-06 |
DE69616484T2 true DE69616484T2 (de) | 2002-04-04 |
Family
ID=9485442
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69616484T Expired - Fee Related DE69616484T2 (de) | 1995-12-13 | 1996-12-12 | Verwendung vom 3-Alpha-Hydroxy-5Alpha-Androsta-16-ene als Arzneimittel |
Country Status (9)
Country | Link |
---|---|
US (1) | US5696107A (de) |
EP (1) | EP0779075B1 (de) |
JP (1) | JPH09176183A (de) |
AT (1) | ATE207750T1 (de) |
DE (1) | DE69616484T2 (de) |
DK (1) | DK0779075T3 (de) |
ES (1) | ES2162992T3 (de) |
FR (1) | FR2742337B1 (de) |
PT (1) | PT779075E (de) |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR676202A (fr) * | 1928-06-06 | 1930-02-20 | Serrure à pène applicable aux portes fermant à gauche et à droite | |
JPS62501909A (ja) * | 1985-01-25 | 1987-07-30 | モネル ケミカル センシス センタ− | ヒト女性における黄体期不全及び無***を治療する為のアンドロステノ−ル及び硫酸デヒドロエピアンドロステロンを含む男性エッセンスの使用 |
US5155045A (en) * | 1985-01-25 | 1992-10-13 | Trustees Of The University Of Penn. | Use of male essence to alter female endocrine response |
JPH01115892A (ja) * | 1987-10-29 | 1989-05-09 | Mitsubishi Electric Corp | 液相成長装置 |
US5272134A (en) * | 1992-03-24 | 1993-12-21 | Erox Corporation | Fragrance compositions and other compositions which contain human pheromones |
FR2717690B1 (fr) * | 1994-03-24 | 1996-04-26 | Roussel Uclaf | Application de stéroïdes aromatiques 3 substitués par un aminoalcoxy substitué à l'obtention d'un médicament pour contrôler la stérilité, notamment masculine. |
AU5426596A (en) * | 1995-05-16 | 1996-11-29 | Salk Institute For Biological Studies, The | Modulators for new members of the steroid/thyroid superfamily of receptors |
-
1995
- 1995-12-13 FR FR9514750A patent/FR2742337B1/fr not_active Expired - Fee Related
-
1996
- 1996-12-12 EP EP96402710A patent/EP0779075B1/de not_active Expired - Lifetime
- 1996-12-12 DE DE69616484T patent/DE69616484T2/de not_active Expired - Fee Related
- 1996-12-12 JP JP8351780A patent/JPH09176183A/ja active Pending
- 1996-12-12 AT AT96402710T patent/ATE207750T1/de not_active IP Right Cessation
- 1996-12-12 PT PT96402710T patent/PT779075E/pt unknown
- 1996-12-12 DK DK96402710T patent/DK0779075T3/da active
- 1996-12-12 US US08/764,142 patent/US5696107A/en not_active Expired - Fee Related
- 1996-12-12 ES ES96402710T patent/ES2162992T3/es not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
ES2162992T3 (es) | 2002-01-16 |
FR2742337B1 (fr) | 1998-03-06 |
DE69616484D1 (de) | 2001-12-06 |
ATE207750T1 (de) | 2001-11-15 |
EP0779075A1 (de) | 1997-06-18 |
FR2742337A1 (fr) | 1997-06-20 |
PT779075E (pt) | 2002-04-29 |
JPH09176183A (ja) | 1997-07-08 |
US5696107A (en) | 1997-12-09 |
EP0779075B1 (de) | 2001-10-31 |
DK0779075T3 (da) | 2002-02-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69627042D1 (de) | Isocumarinderivate und deren verwendung in medikamenten | |
FR2706456B1 (fr) | Dérivés optiquement actifs de 2-imidazoline-5-ones et 2-imidazoline-5-thiones fongicides. | |
ATE167476T1 (de) | Substituierte 2-phenyl-3-methocypropensäurenester als fungizide mittel. | |
ATE199250T1 (de) | Sulfonamidocarbonylpyridin-2-carbonsäureamide und ihre verwendung als arzneimittel | |
ATE172957T1 (de) | Fluoroalkenyl verbindungen und ihre verwendung als schädlingsbekämpfungsmittel | |
DE69629755D1 (de) | Irbesartanhaltiges Arzneimittel | |
ATE94869T1 (de) | Diphenylheteroalkylderivate, ihre herstellung und daraus hergestellte arzneimittel und kosmetika. | |
ATE121295T1 (de) | Augentropfenarzneimittel. | |
NO944406D0 (no) | Nye 7 se inhibitorer | |
ATE172975T1 (de) | Benzimidezolderivate mit antidiabetischer und anti-plättchenklumpungswirkung | |
DE69632533D1 (de) | Intrapulmonare verabreichung vom hematopoietischem medikament | |
DE59407431D1 (de) | Verwendung aromatischer Carbonsäurederivate zur Herstellung von pharmazeutischen Präparaten | |
ES2127181T3 (es) | 11-beta-aril-gona-4,9-dien-3-onas. | |
FR2687910B1 (fr) | Presentoir d'instrumentation dentaire. | |
AU1643592A (en) | Novel compound and use of the same as medicine | |
ATE183088T1 (de) | Arzneimittel zur behandlung von hauterkrankungen | |
DE69616484T2 (de) | Verwendung vom 3-Alpha-Hydroxy-5Alpha-Androsta-16-ene als Arzneimittel | |
FR2710539B1 (fr) | Ensemble d'aiguille chirurgicale. | |
DE69124415D1 (de) | Verwendung von 15-Dehydroxy-16-Oxoprostaglandin bei der Behandlung von allergischen Erkrankungen | |
ES2091570T3 (es) | Nuevos derivados peptidicos antagonistas de la bradiquidina, su procedimiento de preparacion y composiciones farmaceuticas que los contienen. | |
ATE119394T1 (de) | Verwendung von myricetin-3-0-beta-d-glucuronid als arzneimittel. | |
DE69204733D1 (de) | Antibiotikverbindungen und ihre Herstellung. | |
DE68906437T2 (de) | L-pyroglutamyl-l-cystein-dipeptid mit hoher anti-cataractogener wirkung und dies enthaltende pharmazeutische zusammensetzungen. | |
ATE157360T1 (de) | Thienocyclopentanonoximether, ihre herstellung und diese enthaltende arzneimittel | |
MX9200600A (es) | Medicamento que contiene lacidipina, para el tratamiento o prevencion de arteriosclerosis. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |